Sign In

Mark Tsirekas

VP Product

Mark Tsirekas is a product leader and entrepreneur with over 10 years of experience in the tech industry.1 He is currently an Advisor at Ithaca Labs, a role he has held since November 2016.1 Tsirekas has a diverse background in product management, having worked for companies such as Meta, ZOE, eBay, and Schibsted Media Group.1

Some key points about Mark Tsirekas:

  1. He was the VP of Product at ZOE, a health tech company, from January 2022 to June 2023.1
  2. Tsirekas founded Timewith, a platform connecting individuals to therapists, and served as its CEO from 2018 to 2020.1
  3. He has experience in advising startups and mature firms on product management, strategy, and early-stage product validation.1
  4. Tsirekas was recognized in the Forbes 30 under 30 list in 2019 for Social Entrepreneurship.1
  5. He holds a Master of Science in Innovation Entrepreneurship and Management, as well as a Master of Science in Computer Science from Imperial College London.1

Currently, Tsirekas is exploring a new venture while working as an advisor part-time.1 His LinkedIn username is indeed tsirekas.2

Highlights

Jul 22 · linkedin

"Everyone wants to be heard, understood, & appreciated".

A universal human truth and one of the most profound lessons in working with others.

Today, I was reminded of this. On my second day of vacation, whilst heading to the beach, we stopped for coffee. As I parked at the café, the parking assistant didn’t react, possibly due to the angle & I accidentally scratched the car behind me.

Immediately, bystanders & coffee drinkers shouted, “You scratched it - it’s damaged!” I felt tense. An older lady started yelling to the owner, as if we would flee. I took a deep breath, accepting this coffee stop would take some time. I approached her, asking if she knew whose car it was. She did & called out to a woman named Aliki, who was setting up her towels across the street.

Aliki rushed over, visibly angry, saying, “I can’t believe this is happening again!” I calmly responded, “I was the one that scratched it, but I think the damage is small, & we’re here to sort it out - please don’t worry.” I wanted to show her I took responsibility & was willing to collaborate. Her reply was curt, “I’ll decide if the damage is small.”

She seemed disproportionately agitated given the situation. I thought "this can't be about me". This thought increased the time between trigger & response & allowed me to focus on her. I recalled her saying “this again” & realized something else must be troubling her. As we inspected the minor scratch, I asked, “You mentioned ‘again’... did something similar happen recently?” She sighed & explained, “Yesterday, the window, & now this.” I said, “… the window?” She said, “Yeah, the window wouldn’t go up, & I now have to check on the car all the time!” I said, “So you have to keep an eye on it all the time? Sounds really stressful. I understand this scratch is the last thing you wanted today. I want to make this as easy as possible.”

As we were exchanging details, I learned it’s been an overall stressful time. Her son is expecting results from the Greek equivalent of the A-levels & likely needs to move out of Athens, adding extra costs. On top of that, this was a new & shared car with her husband, adding to her stress. For her, it was “not just a scratch.”

Living abroad, I was not listed as a driver in the car insurance. This could have been a problem, but I assured Aliki that we’d handle it. She trusted me. When my mother approached with the insurance details, Aliki apologized, admitting her reaction was over the top.

We asked her to join us at the café to wait for the claims adjuster & escape the scorching sun. She softened up. Within minutes, she was sharing stories about her son—his dreams, ambitions, & challenges—. She was lovely. She gave us local tips, expressed gratitude & apologized profusely.

We parted ways with wishes for safe travels.

Everyone wants to be heard, understood, & appreciated. It feels good, it’s the human thing to do & oftentimes, it pays off.

H/t Robert Morton, PCC.

Feb 5 · linkedin

I am starting to think "Scientific News" is becoming damaging to public healthcare and should be monitored for "reliability" just like fake news.

News needs the drama for clicks. Hope, Fear, Anger. More often than not, they are imprecise, misguide people and I believe drive an "Unsubstantiated Optimism Fatigue" phenomenon. This is particularly true for #chronicdiseases and fatal diseases like #neurodegenerativediseases.

Let me explain. I read the other day an article about "Nasal Lymphatic Network Crucial for Brain CSF Drainage" in Neuroscience News.

Fantastic. I hope for 1000 of those discoveries per day. However, my friend, this is on mice. This means at BEST 15 years away (first observational studies on humans, then utilizing the insights for drug targets... then trials... then phases 1..2.. you get the point). In #alzheimers we are waiting 3 years for a trial simply because patient recruitment is hard. Let that sink in. Also, there's nothing about the study itself. How is one to know of the legitimacy of the results?

Meanwhile, a worried person reads the headline and gets optimistic. Then visits a GP and gets disappointed.

The cognitive dissonance causes a disconnect: "Why am I reading all the time about stuff happening but my Doctor is all doom and gloom? Maybe they don't know!"

As a result, the public becomes alienated from the "slow" #healthcare system, and trust in #medical professionals decreases (for no good reason) causing damage. This is a fact and I posit, a related one. (Link in comments)

"I am reading all this good news, why is my doctor telling me this is incurable?" Because it (currently) is.

I am starting to think every piece of scientific news should be accompanied by details about the study backing the news and a simple "grade" for it.

To evaluate any research we need to consider aspects like the sample size and selection, what is the study design, what are the methodologies employed, the reproducibility (or lack thereof) of results, generalizability to broader populations, potential long-term effects etc, etc.

Otherwise, I think we are giving false hope to people and that is backfiring.

Related Questions

What are some of the key projects Mark Tsirekas has worked on at Ithaca Labs?
How has Mark Tsirekas' experience at Meta influenced his work at Ithaca Labs?
What specific strategies does Mark Tsirekas use for product-led growth?
Can you provide examples of successful product development under Mark Tsirekas' guidance?
What are the main challenges Mark Tsirekas has faced in his career, and how has he overcome them?
Mark Tsirekas
Mark Tsirekas, photo 1
Mark Tsirekas, photo 2
Add to my network

Location

United Kingdom